InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: Amatuer17 post# 155293

Monday, 07/18/2016 5:48:58 PM

Monday, July 18, 2016 5:48:58 PM

Post# of 403217
Views are changing as information coming out changes.

Competition in the ABSSSI area isn't really an issue to me since I had been looking at it as the drug to make it to FDA approval the fastest.

My thinking has changed quite a bit now that Prurisol has shown efficacy.

One thing for sure, I'm a lot happier seeing multiple drugs showing efficacy and having trial reprioritizing as an issue instead of just having one drug with unknown efficacy. It's a good problem to have and should be an interesting story to follow.








In Reply to 'Amatuer17'
Funny to see change in view.

2 years back ABSSI was supposed to the top area to draw huge valuation.
When the competition was highlighted - it was said that B is different class and the single dose will be winner and competition does not matter.






To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News